Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Study Identifier
P13-170
CT.gov Identifier
NCT01464333
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Protocol
Available Language(s): English
Download document(s)
Statistical Analysis Plan
Available Language(s): English
Download document(s)
Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Crohn's Disease (CD)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients with Crohn's disease indicated for Humira treatment with the recommended dosage regimen * Patients with no past- or present malignant tumors * Patients who are not currently receiving Humira
    Exclusion Criteria:
    * None.

    Protocol Summary

    This study of Humira will be conducted to obtain information on the safety (especially profile of malignant tumors and serious infections) and effectiveness in patients with Crohn's disease who are receiving Humira for a long period of time.

    Study Locations

    No locations found.